Skip to main content
. 2020 Jul 21;10(7):e033308. doi: 10.1136/bmjopen-2019-033308

Table 1.

Eligibility criteria

Eligibility criteria Include Exclude
Publication type
  • Peer-reviewed, full-length publications of original data.

  • Non-original data publications; editorials, reviews, letters, opinion pieces, miscellaneous reports, non-empirical studies.

  • Publications written in English.

  • Publications in any language other than English.

  • All articles on the topic published between 1985 and May 2019.

Population type
  • Studies that include participants with dementia of the Alzheimer’s type and/or its prodromal states.

  • Studies that only address non-cognitively impaired adults or adults without memory complaints.

  • Studies with participants that are healthy and participants with cognitive impairment or memory complaints if the data for cognitively impaired participants is reported.

  • Studies with no age matched comparison (control) group.

  • Studies conducted on humans only.

  • Studies on children or adults with the mean age under 60.

  • Studies conducted on humans and other animals if data for humans is reported.

  • Studies with an age matched comparison (control) group.

  • Studies on elderly adult participants; mean age of 60 years old or older (If mean age not specified the age range for the subject must start at 60 years old).

Assessment type
  • Studies that use auditory electrophysiological assessments either as a tool for assessing hearing abilities in cognitively impaired adults or as a diagnostic tool for cognitive impairment.

  • Studies that only use auditory assessments that are not electrophysiological.

  • Studies that use a recognised diagnostic criteria, neuropsychological evaluation or medical imaging to diagnose/classify the AD or MCI groups.

  • Non-human studies.

  • Studies that use non-auditory electrophysiological assessments as well as auditory electrophysiological assessments, if the data for the auditory electrophysiological assessments is reported.

Reported outcome
  • Latency and amplitude measures of the auditory electrophysiological assessments.

  • Self-reported outcomes.

AD, Alzheimer’s disease; MCI, mild cognitive impairment.